Perindoprilarginin/indapamid Krka 5 mg/1,25 mg tablete
| Name | Perindoprilarginin/indapamid Krka 5 mg/1,25 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-438717521 |
| Active Substance | perindoprilarginin indapamid |
| Composition | jedna tableta sadrži 5 mg perindoprilarginina (što odgovara 3,395 mg perindoprila) i 1,25 mg indapamida |
| Pharmaceutical Form | Tableta |
| Manufacturer | Krka d.d. Novo mesto, Novo Mesto, Slovenija TAD Pharma Gmbh, Cuxhaven, Njemačka |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.02.2022 |
| MA Period of Validity | 17.02.2027 |
| Classification Number | UP/I-530-09/20-01/279 |
| Registration Number | 381-12-01/38-22-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BA04 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
